Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Project Oncology®

T-Cell Characteristics: Key Players in Bispecific Antibody Treatment Success

ReachMD Healthcare Image
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Comments
  • Overview

    A new direction in cancer treatment has emerged with T-cell bispecific antibodies (BsAbs) as an immunotherapy, specifically for patients with multiple myeloma. Read more on the current and ongoing research of BsAb therapy.

Recommended
Details
Comments
  • Overview

    A new direction in cancer treatment has emerged with T-cell bispecific antibodies (BsAbs) as an immunotherapy, specifically for patients with multiple myeloma. Read more on the current and ongoing research of BsAb therapy.

Schedule9 Oct 2024